A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general populationJan Lubiński, Antonis C. Antoniou, Xianshu Wang et al.|Nature Genetics|2010Cited by 344
Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer riskStéphanie Baert‐Desurmont, Agnès Hardouin, Jacques Mauillon et al.|European Journal of Human Genetics|2015Cited by 17
Low risk of invasive lobular carcinoma of the breast in carriers of <i>BRCA1</i> (hereditary breast and ovarian cancer) and <i>TP53</i> (Li‐Fraumeni syndrome) germline mutationsYoan Ditchi, Patrick R. Benusiglio, Chloé Broudin et al.|The Breast Journal|2018Cited by 16
Gene‐ and pathway‐level analyses of <scp>iCOGS</scp> variants highlight novel signaling pathways underlying familial breast cancer susceptibilityChristine Lonjou, Fabienne Lesueur, Séverine Eon‐Marchais et al.|International Journal of Cancer|2020Cited by 6
Deciphering dual clinical entities associated with <scp><i>TP53</i></scp> pathogenic variants: Insights from 53,085 <scp>HBOC</scp> panel analyses in French laboratoriesEdwige Kasper, Claude Houdayer, Flavie Boulouard et al.|International Journal of Cancer|2025Cited by 4